LONDON,May 23,2024-- Over the course of the flat panel display (FPD) industry\'s history,factory utilization has typically averaged approximately 84%. However,from 3Q22 to 4Q23,as theFPD market strug
PARIS,May 23,2024--GlocalMe®,the digital lifestyle brand under uCloudLink Group Inc. ("uCloudlink") (NASDAQ: UCL),today introduced three new products at VivaTech 2024. The GlocalMe Life
HoneyNaps secures $11.6 million in series B funding,propelling its entry into the American medical market.
CS5001 is the first known ROR1 antibody-drug conjugate (ADC) to demonstrate clinical anti-tumor activity in both solid tumors and lymphomas,and among the top two globally in clinical development.
The unique event,which is among the first global events created to build excitement for the upcoming Olympic Games,sees French andSingaporeans athletes and artists coming together to revitalise the ic
Phase II results reveal median PFS of 12.6 months in patients with CLDN18.2 high or medium expression,including in patients with PD-L1 CPS<5.
